Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
46°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Olink Holding Ab [Publ] ADR
(NQ:
OLK
)
26.08
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Olink Holding Ab [Publ] ADR
< Previous
1
2
3
4
Next >
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
July 11, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
July 10, 2024
From
Thermo Fisher Scientific Inc.
Via
Business Wire
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
July 08, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Recap: Olink Holding Q4 Earnings
March 25, 2024
Via
Benzinga
Olink Holding: Q3 Earnings Insights
November 15, 2023
Via
Benzinga
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
July 05, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
July 03, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
June 11, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
June 06, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
May 30, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
OLK Stock Earnings: Olink Holding Beats EPS, Misses Revenue for Q1 2024
May 13, 2024
OLK stock results show that Olink Holding beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Olink reports first quarter 2024 financial results
May 13, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
April 19, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
April 02, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
OLK Stock Earnings: Olink Holding Misses EPS, Misses Revenue for Q4 2023
March 25, 2024
OLK stock results show that Olink Holding missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Olink publishes 2023 annual report
March 25, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Olink reports fourth quarter and full year 2023 financial results
March 25, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
March 15, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Olink announces change of date for Annual General Meeting
March 08, 2024
From
Olink Proteomics AB
Via
GlobeNewswire
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment
December 30, 2023
At this juncture, the promising proteomics market is too small to be a surefire investment.
Via
The Motley Fool
Olink reports third quarter 2023 financial results
November 15, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
November 05, 2023
From
Olink Proteomics AB
Via
GlobeNewswire
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
November 03, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Should You Still Buy the Nasdaq's Best-Performing October Stocks?
November 03, 2023
Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.
Via
The Motley Fool
Top 5 Health Care Stocks That Should Keep You Up At Night
October 26, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
October 18, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023
October 18, 2023
Via
Benzinga
Crude Oil Moves Lower; Bank of America Profit Beats Expectations
October 17, 2023
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 17, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 17, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.